EXPERIENCE WITH STREPTOKINASE AS A THROMBOLYTIC AGENT.
作者信息
WINCKELMANN G, HIEMEYER V
出版信息
Scand J Clin Lab Invest. 1964;16:SUPPL 79:7-14.
PMID:14199708
Abstract
摘要
相似文献
1
EXPERIENCE WITH STREPTOKINASE AS A THROMBOLYTIC AGENT.链激酶作为溶栓剂的应用经验。
Scand J Clin Lab Invest. 1964;16:SUPPL 79:7-14.
2
EFFECTS OF FIBRINOLYTIC AGENTS AND HEPARIN ON BLOOD COAGULATION IN DOGS.纤维蛋白溶解剂和肝素对犬类血液凝固的影响。
Am J Physiol. 1964 Nov;207:1049-52. doi: 10.1152/ajplegacy.1964.207.5.1049.
3
4
FIBRINOLYTIC THERAPY OF THROMBOEMBOLIC DISEASE.血栓栓塞性疾病的纤维蛋白溶解疗法。
Surg Gynecol Obstet. 1964 Sep;119:495-502.
5
Clinical and pathological studies: thrombolytic activity and related phenomena.
Thromb Diath Haemorrh. 1961;6(Suppl 1):328-9.
6
THE LABORATORY CONTROL OF THROMBOLYTIC THERAPY.溶栓治疗的实验室控制
J Clin Pathol. 1964 May;17(3):287-91. doi: 10.1136/jcp.17.3.287.
7
ENHANCING BLOOD FIBRINOLYTIC ACTIVITY BY A NIACIN COMPOUND. II. ACTIVATION AND NONACTIVATION.一种烟酸化合物对血液纤溶活性的增强作用。II. 激活与非激活
Am J Med Sci. 1965 Jan;249:66-71. doi: 10.1097/00000441-196501000-00011.
8
THE INHIBITORY EFFECT OF LARGE CONCENTRATIONS OF STREPTOKINASE AS RELATED TO PROTEOLYTIC ACTIVITY AND PROACTIVATOR FUNCTION OF HUMAN EUGLOBULIN.高浓度链激酶对人优球蛋白的蛋白水解活性及前活化剂功能的抑制作用
Scand J Haematol. 1964;1:240-56. doi: 10.1111/j.1600-0609.1964.tb00021.x.
9
TREATMENT OF PERIPHERAL VASCULAR OCCLUSION BY STREPTOKINASE PERFUSION.
Scand J Clin Lab Invest. 1964;16:SUPPL 78:23-9.
10
[THE FIBRINOLYTIC THERAPY OF EXPERIMENTAL MASSIVE PULMONARY EMBOLISM IN RABBITS].[兔实验性大面积肺栓塞的纤维蛋白溶解疗法]
Minerva Cardioangiol. 1964 Jan;12:25-8.
Zotero 插件